Cargando…
Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel
Facing the rising cases of with higher fatalities COVID-19, some countries decided to give the third dose of vaccine as a booster. As of 9 January 2022, 90.31% of health workers in Indonesia have received the third dose vaccine. This study aims to provide an evaluation of adverse events following im...
Autores principales: | Hidayat, Rakhmad, Mustika, Alyssa Putri, Avisha, Fhathia, Djuliannisaa, Zlatikha, Winari, Dinisa Diah, Putri, Ria Amiliah, Lisman, Heydi Marizky, Davin, Vandra, Widhani, Alvina, Aini, Muhammad Hafiz, Rahmadani, Meilisa, Istanti, Novita Dwi, Giantini, Astuti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229967/ https://www.ncbi.nlm.nih.gov/pubmed/35746485 http://dx.doi.org/10.3390/vaccines10060877 |
Ejemplares similares
-
Evaluation of SARS-CoV-2 Antibody Response Post Third Dose COVID-19 mRNA Vaccination at Universitas Indonesia Hospital
por: Hidayat, Rakhmad, et al.
Publicado: (2022) -
Factors Affecting the Self-Isolation Monitoring Program for COVID-19 Patients at the Universitas Indonesia Hospital
por: Hidayat, Rakhmad, et al.
Publicado: (2022) -
Ischemic stroke in COVID-19 patients: a cross-sectional study from an Indonesian COVID-19 referral hospital
por: Hidayat, Rakhmad, et al.
Publicado: (2022) -
Universitas Humanística.
Publicado: (1971) -
Universitas Helsingiensis
Publicado: (2009)